CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell 3000 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.31 USD | +2.31% | +0.57% | +41.22% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.22% | 285M | |
+5.31% | 69.91B | |
+10.97% | 9.03B | |
-16.83% | 4.75B | |
+43.48% | 4.31B | |
+3.20% | 3.88B | |
+18.82% | 2.37B | |
-21.36% | 2.26B | |
-29.67% | 2.2B | |
+8.38% | 1.98B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 3000 Growth Index